BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toskich B, Patel T. Radioembolization for hepatocellular carcinoma: The time has come. Hepatology 2018;67:820-2. [PMID: 29023925 DOI: 10.1002/hep.29590] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu M, Shi K, Huang R, Liu C, Yin L, Yong W, Sun J, Wang G, Zhong Z, Gao M. Facile preparation of 177Lu-microspheres for hepatocellular carcinoma radioisotope therapy. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.01.007] [Reference Citation Analysis]
2 De la Garza-Ramos C, Overfield CJ, Montazeri SA, Liou H, Paz-Fumagalli R, Frey GT, McKinney JM, Ritchie CA, Devcic Z, Lewis AR, Harnois DM, Patel T, Toskich BB. Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated. J Hepatocell Carcinoma 2021;8:861-70. [PMID: 34368021 DOI: 10.2147/JHC.S319215] [Reference Citation Analysis]
3 Carrion-martin L, Orcajo Rincón J, Rotger A, Gonzalez-leyte M, Márquez Pérez L, Echenagusia M, Matilla A. Radioembolization in liver tumors. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2019;38:370-81. [DOI: 10.1016/j.remnie.2019.06.005] [Reference Citation Analysis]